Hepatocellular Carcinoma Recurrence Post Direct-Acting Antiviral and Its Relation to Time of Treating Chronic HCV Infection

Assessment of Hepatitis C Virus (HCV) recurrence impact on the patient and survival after liver transplantation.

RECURRENCE RATE OF HEPATOCELLULAR CARCINOMA AFTER TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH DIRECT ACTING ANTIVIRALS: RANDOMIZED CONTROLLED PHASE 3 TRIAL. PRELIMINARY RESULTS

Recurrence of Hepatocellular Carcinoma in Hepatitis (C) Virus Related Cirrhosis Treated with Direct Acting Antiviral Therapy

Post Eradication Assessment of Hepatic ‎Fibrosis in Hepatitis C

EVALUATION OF DURABILITY OF SUSTAINED VIROLOGICAL RESPONSE (S.V.R.) IN CHRONIC HEPATITIS C TREATED PATIENTS

MOLECULAR AND BIOCHEMICAL STUDIES ON HEPATITIS C PATIENTS RELAPSED AFTER SOFOSBUVIR TREATMENT

Effect of Treating Chronic Hepatitis C Infection with Direct-Acting Antivirals on The Risk of Recurrence Hepatocellular Carcinoma

Pretreatment Renal Biopsy Findings as a Predictor of Post Treatment Renal Function in Patients with Hepatitis C Virus Associated Nephropathy: A Prospective Study

ASSOCIATION BETWEEN ANTIBODY TO HEPATITIS C VIRUS AND HBS Ag IN BLOOD DONORS